NCT07128992View on ClinicalTrials.gov

Need-driven Treatment of the Patients With Type 1 Diabetes

Not yet recruitingOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

October 6, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions

Type 1 Diabetes (T1D)Glucose Control

Interventions

OTHER

Control visit interval

Study investigates whether it is safe to extend the interval of routine calendar-based follow-up visits from every 12 to every 24 months in patients with type 1 diabetes.

All Listed Sponsors

lead

Tampere University Hospital

OTHER